BioVie Inc. reported a net loss of $2.79 million for the three months ended March 31, 2025, a substantial improvement from the $8.07 million net loss in the prior year's comparable period. This reduction was primarily driven by decreased research and development expenses and lower selling, general, and administrative expenses.